On 6-8 December an ISHAM workshop on Chromoblastomycosis will take place in Havana, Cuba, 6-8 December 2017

1. Chromoblastomycosis – A Neglected Tropical Disease
Havana, Cuba - December 6th
– 8th
2017
Chairpersons
María T. Illnait-Zaragozi, MD, PhD, Department of Bacteriology-Mycology; Research,
Diagnosis and Reference Centre. Tropical Medicine Institute "Pedro Kourí”, Havana, Cuba.
Flavio Queiroz-Telles, MD, PhD, Department of Public Health, Hospital de Clínicas, Federal
University of Parana, Curitiba, Paraná, Brazil
Scientific Committee
Daniel Wagner de C. L. Santos, MD, MSc – Federal University of Sao Paulo and Special
Laboratory of Mycology (LEMI-Unifesp), Sao Paulo, Brazil
Flavio Queiroz-Telles, MD, PhD, Department of Public Health, Hospital de Clínicas, Federal
University of Parana, Curitiba, Paraná, Brazil.
Jacques F. Meis, MD PhD, FRCPath, FIDSA, FAAM, Department of Medical Microbiology and
Infectious Diseases (C70) Canisius Wilhelmina Hospital (CWZ) Centre of Expertise in
Mycology Radboudumc/CWZ, Nijmegen, The Netherlands.
Organizing Committee
María T. Illnait-Zaragozi, MD, PhD, Department of Bacteriology-Mycology; Research,
Diagnosis and Reference Centre. Tropical Medicine Institute "Pedro Kourí”, Havana, Cuba.
Maria G Guzmán - MD, PhD, President of the Cuban Society of Microbiology and
Parasitology. Head of Research, Diagnosis and Reference Centre. Tropical Medicine Institute
"Pedro Kourí", Director of the WHO/PAHO Center for the Study of Dengue and its Vector
President.
Lic. Mayda R. Perurena Lancha, MSc. Head of Mycology National Reference Laboratory.
Department of Bacteriology-Mycology, Research, Diagnosis and Reference Centre, Tropical
Medicine Institute "Pedro Kourí" Havana, Cuba.Dr.
Gerardo F. Martínez Machín, MD, MSc. Mycology National Reference Laboratory.
Department of Bacteriology-Mycology, Research, Diagnosis and Reference Centre, Tropical
Medicine Institute "Pedro Kourí" Havana, Cuba.
Lic. Carlos M. Fernández Andreu, PhD. Mycology National Reference Laboratory. Department
of Bacteriology-Mycology, Research, Diagnosis and Reference Centre, Tropical Medicine
Institute "Pedro Kourí" Havana, Cuba.

2. International Faculty
Alexandro Bonifaz – Narvart Hospital México City, Mexico
Arnaldo Lopes Colombo, University of São Paulo, São Paulo, Brazi
Arunaloke Chakrabarti, Institute of Medical Education & Research
Chandigarh, India
Claudio Guedes Salgado, Federal University of Pará, Belém, Pará, Brazil
Conceição Pedrozo, University of Maranhao, São Luis, Brazil
Daniel Wagner C Santos – São Paulo, Brazil
David Denning, University of Manchester, England
Flavio Queiroz-Telles, Hospital de Clínicas, Federal University of Parana, Curitiba, Brazil
Jacques F. Meis, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands
Lala Soavina Ramarozatovo, Medical School of Artananarivo, Madagascar
Liyan Xi, Sun-Yat Sen Hospital, Guangzhou, China
Peiying Feng, Sun-Yat Sen Hospital, Guangzhou, China
Sybren de Hoog, Westerdijk– Utrecht University, CBS Fungal Biodiversity Centre, Utrecht, The
Netherlands
Vania Aparecida Vicente, Federal University of Paraná, Curitiba, Brazil

3. PRELIMINARY SCIENTIFIC PROGRAM
December 6th – Wednesday
18:00h Opening ceremony.
María T. Illnait-Zaragozi, Flavio Queiroz-Telles, Cuban authorities
Key lecture: From South Star, Brazil to Genève, Switzerland. A long
journey in the chromoblastomycosis history.
Flavio Queiroz-Telles, Brazil.
December 7th – Thursday
Epidemiology around the globe
Coordinators: Jacques Meis, The Netherlands.
Maria T. Illnait-Zaragozi, Cuba.
9:00h The burden of chromoblastomycosis in the world.
Daniel Wagner Santos, Brazil.
Global Eco epidemiologic aspects of chromoblastomycosis:
In Latin America
Alejandro Bonifaz, Mexico.
In Africa,
Lala Soavina Ramarozatovo
In Madagascar In Asia and Oceania
Lyan Xi, China.
In India
Arunaloke Chakrabarti
Discussion.
Break.
Mycology
Coordinators: Sybren de Hoog, The Netherlands.
Vania Vicente, Brazil.
An update on the taxonomy of the chromoblastomycosis etiologic agents.
Sybren de Hoog, The Netherlands.
Phenotypic and genotypic identification of the principal
chromoblastomycosis agents.
Peiying Feng, China.
Genomic aspects of Fonsecaea spp: clinical correlation and environmental
aspects.
Vania Aparecida Vicente, Brazil.
Diagnosis of chromoblastomycosis in clinical practice.
Maria T Illnait-Zaragozi, Cuba.
Discussion.
Break.

4. Immunology and pathogenesis
Coordinators: Claudio Salgado, Brazil.
Maria T. Illnait-Zaragozi, Cuba.
Overview of the present immunology context of Chromoblastomycosis
Claudio Salgado, Brazil.
Cellular immune response in patients with chromoblastomycosis.
Conceiçao Pedroso, Brazil.
Environmental melanized fungi as a potential source for the disease.
Vania Vicente, Brazil.
Muriform cells: the hallmark of Chromoblastomycosis
Sybren de Hoog, the Netherlands.
Discussion.
Break.
The clinical spectrum of Chromoblastomycosis
Coordinators: Sergio Cimerman, Brazil.
Gerardo F. Machín, Cuba.
From the initial lesion to the disseminated forms.
Peiying Feng, China.
Diseases that look like Chromoblastomycosis.
Alejandro Bonifaz, Mexico.
Grades of severity and parameters for cure.
Flavio Queiroz-Telles, Brazil.
Sequels and incapacity.
Claudio Salgado, Brazil.
Discussion.
Current therapy of Chromoblastomycosis
Coordinators: Jacques Meis, The Netherlands.
Arnaldo Colombo, Brazil.
The role of the non-medical treatment methods.
Lyian Xi, China.
Antifungal susceptibility of melanized fungi.
Arnaldo Colombo, Brazil.
Systemic therapy in 2017.
Daniel Wagner Santos, Brazil.
Future therapeutic perspectives.
Jacques Meis, the Netherlands.
Discussion.
Break.
Keynote lecture Chromoblastomycosis – A true neglected tropical
disease.
David Denning, England.
Closure and adjourns

5. To Professor Ricardo C. Zapater, Universidad Nacional de Buenos Aires, Argentina

6. Sponsored by
Supporters